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ABSTRACT  Fragments of  vimentin,  generated by  chemical  or  enzymatic  cleavages, were 
analyzed for their capacity to bind to human inverted erythrocyte  membrane vesicles. Only 
peptides comprising the amino-terminal head domain of vimentin  molecules were competent 
in associating with the membranes. In vitro  studies also demonstrated that isolated ankyrin 
(the major vimentin acceptor site on the membrane) binds to an oligomeric species of vimentin 
and prevents the formation of characteristic 10-nm filaments. These data, taken together with 
the observation that the  NH2-terminal end of vimentin  is implicated  in the polymerization 
process (Traub, P.,  and  C.  Vorgias, J.  Cell  Sci.,  1983, 63:43-67),  imply  that  intermediate 
filaments may contact the membrane in an end-on fashion, using the exposed head domains 
of their terminal subunits. 
Vimentin  binds to  inverted  human  erythrocyte membrane 
vesicles,  or inside-out membrane vesicles (IOVs)  t through a 
high-affinity association with ankyrin, one of the major com- 
ponents of the membrane skeleton (1). The characteristics of 
the association suggest that ankyrin may serve as an attach- 
ment site for intermediate filaments through an end-on asso- 
ciation mechanism. Vimentin possesses a tripartite molecular 
substructure  composed  of a  head  piece,  a  helical  middle 
domain, and a tail region (2, 3). It undergoes polymerization 
via lateral associations of individual monomers followed by 
an elongation of short protofilaments, to form extended  10- 
nm  filaments  (4).  The  amino-terminal  head  domains  are 
implicated in this latter step (5). 
The studies described below show that vimentin molecules 
bind to membranes through their amino-terminal domains, 
and,  as  it  could  be  expected,  the  binding  of ankyrin  to 
vimentin oligomers inhibits the formation of higher polymers 
in vitro. 
Abbreviations used in this paper:  IOVs, inside-out membrane ves- 
icles;  NTCB,  2-nitro-5-thiocyanobenzoic acid;  PMSF,  phenylmeth- 
ylsulfonyl fluoride. 
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MATERIALS AND  METHODS 
Chemicals:  a-Chymotrypsin  was  purchased  from Worthington  Bio- 
chemical Corp., (Freehold, N  J) trypsin from Miles Laboratories, Inc., (Elkhart, 
IN). 2-Nitro-5-thiocyanobenzoic acid (NTCB) was synthesized according to the 
method of Degani and Patchornic (6). 
Purification  of Vimentin:  In a typical experiment, 50 calf lenses(44- 
50 g) were homogenized in phosphate-buffered saline (PBS) containing  2 mM 
MgCI2, 5 mM 2-mercaptoethanol  and  I  mM phenylmethylsuli'onyl tluoride 
(PMSF) (pH 7.4) at 4"C. After centrifugation  in  a JAI4 Beckman  rotor at 
14,000 rpm for 40 rain,  the pellet was extracted for 15 rain with 0.6 M KCI, 
50 mM Tris-HCl, 2 mM MgCI2, 5 mM 2-mercaptoethanol,  1 mM PMSF,  1 
mM NAN3, and  0.5% Triton X-100  (pH 7.4) on  ice; it was then  Dounce- 
homogenized (12 strokes) and spun for 45 rain.  This procedure was repeated 
three times. The final pellet was washed with 150 mM KCI, 5 mM Tris-HCl, 5 
mM 2-mercaptoethanol,  1 mM PMSF, and  1 mM NaN3 (pH 7.4), and then 
extracted with 7 M urea, 2 mM Tris-HCl,  10 mM EDTA, 5 mM 2-mercapto- 
ethanol,  I mM PMSF (pH 7.4) (3 h at 23°C or 8 h at 4°C with 6 M area). The 
extract was high-speed centrifuged (100,000 g for 30 min) after dilution  (1:1) 
with double-distilled water, and the supernate was collected. Urea was removed 
by dialysis against 2 mM Tris-HCI,  1 mM EDTA, 5 mM 2-mercaptoethanol, 
0.2  mM  PMSF  (pH  7,4), and  vimentin  was precipitated  with  ammonium 
sulfate at 23* saturation.  The precipitate was resuspended in 6 M urea, 5 mM 
Tris-HCl,  1 mM EDTA, 2 mM 2-mercaptoethanol,  0.1  mM PMSF (pH 7.6), 
and dialyzed against the same buffer. ARer adjustment  of the protein concen- 
tration  to  -1  mg/ml, this  material  was combined  batchwise  with  DEAE- 
cellulose (DE52) equilibrated in the same buffer, shaken for 30 min at 4°C, and 
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into a column, washed with another 2 bed volumes of  buffer, and finally eluted 
with a 0-300-raM  NaCI gradient. Vimentin-containing  fractions were identified 
by SDS PAGE,  pooled, dialyzed  for 2-3 d  against  3 mM NaPO4, 0.1  mM 
EDTA, 2 mM 2-mercaptoethanol,  and 0.1 mM PMSF (pH 7.4), and the protein 
concentration  was adjusted to 0.1-0.4  mg/ml. The preparation  was kept in  l- 
ml aliquots at 0*C and remained stable over the course of at least 1 ran. Upon 
addition  of salt (to  isotonic) characteristic  10-nm filaments  were formed  in 
vitro. (The purification and radiolabeling of vimentin are shown in Fig. 8.) 
Purification  of Ankyrin:  Ankyrin was isolated from human erythro- 
cyte ghosts as previously described (7). 
Chymotryptic  Cleavages of Vimentin:  Digestion  of purified 
vimentin was performed at 23"C with a-chymotrypsin at an enzyme to substrate 
ratio of 1:250 for 1, 15, and 30 min or at 4"C for 2 min. Digestion was stopped 
by the addition  of PMSF to  1.3  mM and cooling on ice. Digests remained 
stable for at least 1 wk. 
Chemical Cleavage of Vimentin:  Purified vimentin (200 t~g/ml) 
was made 6 M in urea by the addition  of solid urea, and then dialyzed against 
6  M  urea,  40  mM  Tris-HCl,  1 mM  EDTA,  and 0. l  mM  PMSF (pH 8.0). 
NTCB was then added at 2 mM and the preparation  was incubated for 40 min 
at room temperature.  After that, the pH was raised to 9 by the addition of Tris 
base and the reaction mixture was incubated at 37"C for 4 and 8 h. The reaction 
was stopped by the addition of 2-mercaptoethanol  to l0 mM and samples were 
subsequently dialyzed extensively against 3 mM NaPO4, 0. l mM PMSF, 2 mM 
2-mercaptoethanol  (pH 7.4). 
Radiolabeling Procedures:  Purified  vimentin  (at  90-100  zg/ml), 
or NTCB-cleaved  vimentin (220 zg/ml) were dialyzed against 50 mM NaPO4 
(pH 8.1) and then  reacted  with low-specific activity (500 Ci/mmol) Bolton- 
Hunter reagent-! '2~. Reaction  was allowed to proceed for 30 min at 0*C after 
which the proteins  were extensively dialyzed against 3 mM NaPO4, 0.1  mM 
EDTA, 1 mM PMSF (pH 7.4). Specific activities varied between 50 and 70,000 
cpm/zg. Protein-bound  radioactivity was estimated to 99. 1% after precipitation 
with trichloroacetic  acid (10%) at 0*C, in the  presence of 3%  bovine serum 
albumin (BSA) (carrier protein). 
Immunoprecipitation:  lt25-Vimentin (33,000 cpm/#g)  was  incu- 
bated with  17 ug/ml of isolated ankyrin  (30 min in 20 mM KCI, 5 mM Tris, 
0.5 mM PMSF [pH 7.4] and 30 min at  100 mM KCI, l0 mM Tris, 0.1  mM 
PMSF [pH 7.4]) at 23"C in a final volume of 100/JI and in the presence of  0.1 
mg/ml BSA. After that,  3 ttl of anti-ankyrin  antiserum or nonimmune serum 
were added, and the proteins were incubated for an additional  30 min at 23"C. 
20 ~1 of a Staphylococcus aureus suspension were then pipetted and, after  15 
min, the samples were centrifuged (5 min in a minifuge). Pellets were washed 
five times with 100 mM KCI, 10 mM Tris, 0.1 mM PMSF (pH 7.4) containing 
0.06%  Triton  X-100.  The  combined  supernates  and  the  pellets were then 
counted in a gamma counter. 
Sedimentation Assays:  l~25-Vimentin  (10,000 cpm/ug) and purified 
ankyrin  were prespun at 25  psi for 30  rain in an airfuge. Then,  increasing 
amounts of ankyrin were incubated  for 30 min with vimentin in 20 mM KCI, 
5 mM Tris, 0. l mM PMSF (pH 7.4) at 23"C (or alternatively in PBS/10). After 
this incubation,  the salt was adjusted to 100 mM KCI, l0 mM Tris, 2 mM 2- 
mercaptoethanol  (pH 7.4), and an additional  60-rain  incubation  ensued.  In 
some cases, the two proteins  were simply dialyzed together  against  low salt 
(overnight at 4"C) and then against PBS (3 h at 23"C). The samples were placed 
in airfuge tubes over a  100-ul cushion of 10% sucrose in the assay buffer and 
spun for 30-35 min at 25 psi. The tubes were next frozen in liquid N2, dissected 
with a razor blade (supernate/pellet)  and counted as above. 
Negative Staining:  Vimentin  alone (300 ug/ml) or vimentin  mixed 
with ankyrin were prespon and incubated as described above for the sedimen- 
tation assays. 30 ~1 of  each sample were then applied to glow-discharged electron 
microscope grids for 1 rain at room temperature.  Excess liquid was removed 
by capillary action  and phosphotungstic  acid (3%  phosphotungstic  acid pre- 
pared fresh) was added for 2 min after which 1% uranyl acetate was applied for 
1 additional  min. Grids were visualized in a Phillips 300 electron microscope. 
Electrophoresis:  One- and two-dimensional  electrophoresis was per- 
formed as previously described (8, 9). 
Protein concentrations  were measured  by the method  of Lowry (10) using 
BSA as a standard. 
RESULTS 
Vimentin Binds to IOVs through its Head Domain 
Treatment of vimentin with NTCB is known to cleave the 
polypeptide  chain  at  a  single  cysteine  residue,  137  amino 
acids from the COOH-terminal, and to separate the molecule 
into two  segments.  One  (C-I) contains the  amino-terminal 
head domain and part of the middle domain and the second 
(C-II) is composed of the tail region and the remainder of the 
middle  segment  (2,  3).  When the two  NTCB  fragments  of 
vimentin are  incubated with IOVs under physiological con- 
ditions, only one, the C-I  fragment  binds selectively  to the 
surfaces of the IOVs (Fig.  1). The specificity of the binding of 
this  37,000-mol-wt  fragment  to  IOVs  is  demonstrated  by 
showing that unlabeled intact vimentin molecules were able 
to quantitatively displace  both labeled  intact vimentin  and 
the labeled  C-I  peptide  (Fig.  2).  The  data  shown in  Fig.  2 
show that unlabeled intact  vimentin  molecules  are  able  to 
displace labeled vimentin molecules to a greater extent than 
the  labeled  C-I  peptides,  as  would  be  expected  from  the 
difference in molar concentrations of the two peptides. (The 
molar  ratio  between  C-I  and  uncleaved  vimentin  in  this 
particular  digest was estimated to  1.52:1).  It is worth noting 
that  some  products  of  endogenous  degradation  (probably 
lacking the head domain and migrating between uncleaved 
vimentin and C-I or between CI and CII) also partition with 
the supernate. 
Since the C-I  peptide derived from vimentin is composed 
of both the  head domain  of the  molecule  and  part  of the 
middle segment, further analysis was carried out using limited 
chymotryptic digestion. Brief incubations of intact vimentin 
with low concentrations of chymotrypsin at room tempera- 
ture produced a series  of peptides with molecular weights of 
55,000, 50,000, 47,000, and 45,000. This characteristic  "stair- 
FIGURE  1  Binding of 112S-vimentin  NTCB fragments to IOVs. 55 #g 
of IOVs were incubated with 2.25 #g of 112S-vimentin  NTCB frag- 
ments in  PBS at pH 7.4 and in a final volume of 110 #1. After 90 
min, the reaction mixture was centrifuged through a 150-~1  cushion 
of 4% isotonic-sucrose, and the supernate and pellet were analyzed 
by SDS PAGE. (Panel A) Coomassie Blue-stained SDS gels. Super- 
hate (a) and pellet (b). The major band in a is the band 6 polypep- 
tide. (Panel  B) Autoradiograms of the a and b fractions of panel A. 
(Panel C) Autoradiogram of the NTCB digest (without IOV; 4.5 #g). 
V,  Uncleaved vimentin; C~, amino-terminal NTCB fragment  of vi- 
mentin; C,, COOH-terminal NTCB-fragment of vimentin. 
GEORGATOS lET AL.  Vimentin-Membrane  Interactions  ] 963 FiGure 2  Displacement of 112S-vimentin  NTCB fragments bound to IOVs  by unlabeled, intact  vimentin. 20 ~.g of IOVs were 
incubated with a standard amount of NTCB fragments of 112S-vimentin  (1.1 /~g) and 0/Lg (2), 1.5 #g (3), 3.5/~g (4), and 5.25/~g (5) 
of unlabeled, intact vimentin in PBS (pH  7.4), and in a final volume of 100/~l. Sample 1 contained only IOVs. All five samples 
were processed as in Fig. 1. (Panel A) 1-5 (/eft), pellets; 1-5 (right),  supernates (Coomassie-stained  gel). (Panel B) Corresponding 
autoradiogram.  Arrowheads denote (from top to bottom) the positions of intact 112S-vimentin,  G, and C,. 
FtGURE 3  Binding of chymotryptic fragments of vimentin to IOVs. 15/~g of purified vimentin were digested at room temperature 
for various times with a-chymotrypsin. The reaction was stopped by the addition of PMSF to a final concentration of 1.5-2.0 
mM. The digests were incubated with IOVs in PBS, 0.5 mM PMSF for 90 min at 23°C, processed as in Fig. 1, analyzed by SDS 
PAGE, and stained by Coomassie Blue. (Panel A) (1) 55/~g of IOVs incubated with a blank sample (no vimentin; ~-chymotrypsin 
inhibited by PMSF); (2 and 7) 55 #g of IOVs incubated with a 30-rain vimentin digest; (3 and 6) 55 ~g of IOVs incubated with a 
10-min digest; (4 and 5) 55 pg of IOVs incubated with 15/~g of undigested vimentin. 1-4 correspond  to the membrane pellets 
and 5-7 to the supernates. The position of band 6 is indicated by a dash. Arrows point to the two major vimentin peptides with 
molecular weights of 45,000 and 22,000 (10% gel). (Panel/3) (I) 20/~g of IOVs incubated with a blank sample as in A. (2 and 5) 
20/~g of IOVs and 10 #g of a 30-s digest; (3 and 6) 20 pg of IOVs and a 1-min digest; (4 and 7) 20 #g of vimentin and a 2-min 
digest.  1-4 correspond to the membrane pellets and 5-7 to the supernates (7.5-15% gradient gel). Arrows indicate the major 
early fragments with apparent molecular weights of 50,000, 47,000, and 45,000. Band 6 is indicated by dash. 
1964 case pattern" of vimentin degradation results from a gradual 
cleavage of the  vimentin  molecule from the  basic  amino- 
terminal end as indicated by two-dimensional gel electropho- 
resis (not shown; see reference 12). More extensive degrada- 
tion of vimentin produced mainly a 45,000-mol-wt peptide, 
analogous to  desmin's  40,000-mol-wt  middle  piece  (2,  4), 
then cleaved into a 22,000-mol-wt broad band analogous to 
the 21,000- and  18,000-mol-wt subfragments of desmin de- 
rived from the middle segment. After appropriate inhibition 
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FIGURE  4  Binding of 112S-vimentin  to isolated ankyrin as detected 
by rate zonal centrifugation. 1~2S-vimentin  (100 pg/ml) was incubated 
with a threefold molar excess of ankyrin for 2.5 h at 4°C in PBS, 2 
mM MgCl2, 2 mM 2-mercaptoethanol,  0.1 mM PMSF (pH 7.4), and 
centrifuged for 19 h in a Beckman 40 Ti rotor (40,000 rpm) at 4°C. 
O, vimentin alone; @, vimentin and ankyrin; A, ankyrin alone. 
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FIGURE  5  Binding of 1~25-vimentin  to isolated ankyrin as detected 
by immunoprecipitation with a polyclonal anti-ankyrin antibody. A, 
@, two separate assays  with 112Lvimentin,  ankyrin, and anti-ankyrin 
(as specified in Materials and Methods)  are shown. A, controls  (no 
ankyrin added); O, assay with normal rabbit serum instead of anti- 
ankyrin. 
of residual chymotryptic  activity, the different digest fractions 
were analyzed for their capacity to  bind to  IOVs.  Of the 
digests analyzed, no fragment showed appreciable capacity to 
bind to IOVs (Fig.  3), a result consistent with the idea that 
the active site of vimentin is contained within the protease- 
sensitive amino-terminal  domain  and  not in  the  protease- 
resistant middle piece. 
Ankyrin  Inhibits the Assembly of Intermediate 
Filaments In Vitro 
Vimentin and ankyrin form a specific complex in vitro that 
can be demonstrated by sucrose gradient centrifugation (Fig. 
4). Vimentin alone at 100 pg/ml sediments predominantly as 
a 6-7S species under physiologic salt and pH conditions. The 
addition  of excess ankyrin causes a  significant shift in  the 
migrating peak (Fig. 4). Incubation of vimentin preparations 
with threefold excess ankyrin also causes a significant decrease 
in  the  amount  of pelleted  (filamentous)  vimentin  that  is 
formed under these conditions. 
The association between ankyrin and  vimentin was  also 
analyzed using a radioimmunoassay with anti-ankyrin anti- 
bodies. The data in Fig. 5 show that the association between 
vimentin and ankyrin was concentration-dependent and sat- 
urable, and corresponded roughly to a  l: 1 molar stoichiome- 
try,  assuming  a  tetrameric  organization  for the  vimentin 
oligomer (4). 
Based on the results of the sedimentation experiments and 
the  fact  that  the  head  domain  of the  vimentin  molecule 
seemed to bind specifically  to IOVs,  we considered it likely 
that ankyrin might affect the capacity of vimentin molecules 
to polymerize into intermediate filaments by binding to the 
head domains of the protofilaments and thereby blocking the 
arginine-rich regions that are thought to be involved in the 
assembly process (5). This question was approached by two 
independent methods.  Vimentin was assembled in  vitro in 
the presence of increasing amounts of ankyrin, and the rela- 
tive amounts of  polymer  that were sedimented were correlated 
with the ankyrin-vimentin ratio in the original reaction mix- 
ture. The data in Fig. 6 show that there is a decrease in the 
relative amount of vimentin species greater than  54S  as a 
function of increasing ankyrin concentrations. In contrast, if 
vimentin polymers were preassembled and  then incubated 
with increasing amounts of ankyrin for the same time inter- 
vals, such a decrease was not detected (Table I). These results 
are further supported by the fact that only small amounts of 
ankyrin co-pelleted with prepolymerized vimentin under the 
same conditions (not shown). 
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FIGURE 6  Effect  of ankyrin on  vimentin's 
polymerization as detected  by sedimenta- 
tion. Under the conditions of these experi- 
ments  (details  in  Materials  and  Methods) 
only complexes  greater  than  54S are  pel- 
leted.  (A) A  standard  curve indicated  that 
the relative amounts of vimentin pelleted as 
a function of the protein concentration.  (B) 
The  relative amounts  of vimentin pelleted 
after incubation with increasing amounts of 
ankyrin (nonassembled  vimentin at 60 pg/ 
ml). All samples were precentrifuged  before 
the assays. 
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vimentin into intermediate filaments was demonstrated most 
strikingly by analyzing preparations of ankyrin and vimentin 
by negative staining and electron microscopy (Fig. 7). Char- 
TABLE I 
Effect of Ankyrin on the Stability  Of Pre-assembled Vimentin 
Polymers under In Vitro Conditions 
Concentration of  Percent pelletable 
vimentin  Ankyrin/Vimentin*  vimentin 
i~g[ml 
60  0  8.3 
60  0.05  9.4 
60  0.35  9.3 
100  0  20 
1  O0  0.05  18.9 
100  0.35  16.4 
200  0  38 
200  0.35  40 
Vimentin was preassembled  in isotonic KCL buffer for 1 h at 23°C and then 
co-incubated  with  isolated  ankyrin  for additional  40  rain.  Samples  were 
processed  as described in Materials and Methods. 
* In molar terms. 
acteristic  10-nm filaments were readily demonstrated by in- 
cubation ofvimentin alone (Fig. 7A), whereas no recognizable 
filament forms were seen when ankyrin and vimentin were 
incubated together before negative staining (Fig. 7, B and C). 
Instead, short rod-like forms were seen scattered throughout 
the  fields.  The  rod-like  forms  had  the  same  approximate 
diameter of vimentin filaments (10-11 nm); this is consistent 
with the idea that lateral association of protofilament units 
did occur, but the elongation of protofilaments was inhibited 
by the presence of ankyrin. 
The purification and radiolabeling of vimentin are shown 
in Fig. 8. 
DISCUSSION 
The results described here and  in  the  preceding paper (1) 
provide new insight into how and where intermediate fila- 
ments may attach to plasma membranes. Intermediate fila- 
ments composed of vimentin are able to bind to |OVs pre- 
pared from human erythrocytes, and they appear to do so by 
associating to an attachment protein, previously identifed as 
ankyrin, which also links other components of the cytoskel- 
FIGURE  7  The effect  of ankyrin on  vimentin  polymerization as detected by  negative staining  and  electron microscopy. (A) 
Vimentin alone (300 ,~g/ml). (B) Vimentin (300 ~tg/ml) and ankyrin at a molar ratio of 4:1. (C) Vimentin and ankyrin at a molar ratio 
of 2:1. x  42,000. 
1966  THE JOURNAL OF CELL BIOLOGY •  VOLUME  t00,  1985 FIGURE 8  Purification and radiolabeling of vimentin. (A) SDS PAGE of various fractions recovered after ion-exchange chroma- 
tography of a urea-extract of lens cytoskeletons. E, material  applied to the column; G, human erythrocyte ghosts; V, vimentin; 
HM, high molecular weight protein; AC, actin. (B) Two-dimensional electrophotogram of purified vimentin. The basic side of the 
gel  is on the right. Vimentin  is focused at  a pH  of 5.3-5.4.  (C) Autoradiogram of a similar two-dimensional gel of iodinated 
vimentin. 
eton to the overlying lipid bilayer. The linkage between vi- 
mentin filaments and ankyrin probably occurs at the free ends 
of the intermediate filament polymers and involves an attach- 
ment of the  "head" portion of the  vimentin molecule to a 
binding site on ankyrin distinct from but probably close to 
the binding site on ankyrin for erythrocyte spectrin (Georga- 
tos, S. D., and D. C. Weaver, manuscript in preparation). 
Current models of vimentin organization postulate that the 
fundamental  unit  of intermediate  filaments  is  a  tetramer 
consisting of four polypeptide chains arranged in two dimeric 
pairs in lateral register (4). The dimers appear to be stabilized 
by noncovalent interactions between adjacent helical domains 
which form a coiled-cold (2, 4). It has been proposed that the 
polymerization  of  vimentin  monomers  into  filamentous 
forms is initiated by specific binding of the arginine-rich head 
domains to the middle, helically coiled segments of neighbor- 
ing protofilaments. This idea is supported by the  following 
lines of evidence. Removal of the head piece of vimentin by 
a  calcium-activated protease inhibits  vimentin  polymeriza- 
tion,  and the  helically coiled middle domains generated by 
this treatment will not polymerize into filaments in vitro (11, 
12). The sensitivity of vimentin to protease cleavage is also 
sensitive to salt concentrations, consistent with the idea that 
once  filament  formation  is  induced,  the  protease-sensitive 
sites on the head groups are less exposed to enzymatic diges- 
tion.  The  portion  of the  head  piece  of vimentin  that  is 
involved  in  initiating  polymerization  seems  to  be  rich  in 
arginine residues, since the addition of excess amounts of free 
arginine  prevent  filament  formation  from  intact  vimentin 
monomers (5). 
The  experiments  described  here  indicate  that  the  head 
portion of the vimentin molecule also plays a critical role in 
the attachment of vimentin filaments to the IOVs and to the 
ankyrin molecule. Since isolated ankyrin molecules bind to 
vimentin  and  also  inhibit  the  polymerization  of vimentin 
oligomers into filamentous forms, it seems feasible to infer 
that the  mode of attachments of vimentin filaments to the 
membrane represents an  association similar in  principle to 
the  mode of association  between  vimentin  protofilaments, 
with the head piece of  the vimentin molecule playing a pivotal 
role. 
If the  mechanisms described above are also operative in 
vivo, it seems logical to hypothesize that membrane-bound 
vimentin does not provide nucleating centers for intermediate 
filament  assembly,  since  the  ankyrin-vimentin  association 
would be expected to inhibit filament growth at the binding 
ends. Thus, centers for nucleation of vimentin filaments that 
are attached to membranes should be located elsewhere inside 
cells, possibly at the nuclear envelope. If  it follows that native 
vimentin intermediate filaments contain distinct  nucleation 
sites  and  membrane  attachment  sites,  such  filaments  also 
assume a distinct polarity within the cell. If only the ends of 
vimentin  filaments  are  capable  of binding  to  membrane- 
bound ankyrin sites,  a  limited number of such sites will  be 
required to attach the number of vimentin filaments usually 
found  inside  cells,  and  this  prediction  agrees  with  earlier 
morphological studies in which it has been demonstrated that 
in certain vimentin-rich cells such as avian erythrocytes, the 
intermediate filaments associate at a relatively few foci along 
the plasma membrane rather than being diffusely distributed 
over the entire cell surface (13). 
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